global countertops market size, by value€¦ · guided therapeutics becton, dickinson and company...

Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV

Testing, Colposcopy and Cervical Biopsies), By Age Group (<35 years,

35 years, >35 years): Forecast to 2022

• By Type - Pap Test, HPV Test, Colposcopy

and Cervical Biopsies.

• By Age Group – Below 35 years and 35

years and above.

• By Region- North America, Europe, Asia

Pacific, and ROW.

• By Country - U.S, Canada, Germany, U.K,

China, India, Mexico and Brazil.

January 2018

2

Global Cervical Cancer Diagnostics

Market – By Value (2012-16)


Market – By Value (2017-22)


Market Breakdown- By Type, By Value

Pap Test

HPV Test

Colposcopy

Cervical Biopsies


Market Breakdown-By Age Group, By

Value

Below 35 years

35 years and above

Global Coverage Regional Coverage

Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical

Biopsies), By Age Group (<35 years, 35 years, >35 years): Forecast to 2022

Cervical Cancer Diagnostics

Market, (2012-2016)


Market, (2017-2022)

By Value

By Type, By Value

By Age Group, By Value

North America

Europe

Asia Pacific

ROW

Country Coverage


Market (2012-2022)

By Value

By Type, By Value

By Age Group, By Value

U.S.

Canada

Mexico

Brazil

Germany

U.K

China

India

Company Coverage

Product Benchmarking

Sales*

Business Overview

Recent Product Approvals

Merger & Acquisition

*for listed companies only.

Hologic, Inc.

Abott Laboratories

Roche Diagnostics

Guided Therapeutics

Becton, Dickinson and Company

Qiagen

Quest Diagnostics

Arbor Vita Corporation

g

Global Coverage

Regional Coverage

Country Coverage

Scope of the Study

Segment Coverage

By Type

By Age Group

Region (North America, Europe, APAC and ROW)

Country (U.S., Canada, Brazil, Mexico, Germany, U.K, China,

and India)

Table of Content

3

S.No Particulars Page No.

1. Research Methodology 20

2. Executive Summary 21

3. Strategic Recommendation 22

3.1 Increasing demand for HPV tests in global cervical cancer diagnostics market. 23

3.2 Asia Pacific Region to witness the fastest growth in cervical cancer diagnostics market in the forecast period.

24

4. Cervical Cancer Outlook 25

5. Global Cervical Cancer Diagnostics Market: Growth and Forecast 38

5.1 By Value (2012-2016) 39

5.2 By Value (2017-2022) 40

6. Global Cervical Cancer Diagnostics Market – Segmental Analysis 47

Table of Content

4


6.1 Global Cervical Cancer Diagnostics Market Size, By Type: Breakdown (%) 47

6.1.1 Global Cervical Cancer Diagnostics Market Size, By Type, 2016 (%) 49

6.1.2 Global Cervical Cancer Diagnostics Market Size, By Type, 2022 (%) 50

6.1.3 Global Pap Test Market, By Value (2012-2022) 51

6.1.4 Global HPV Test Market, By Value (2012-2022) 52

6.1.5 Global Colposcopy Market, By Value (2012-2022) 53

6.1.6 Global Cervical Biopsies Market, By Value (2012-2022) 54

6.2 Global Cervical Cancer Diagnostics Market Size, By Age Group, Breakdown (%) 55

6.2.1 Global Cervical Cancer Diagnostics Market Size, By Age Group, 2016 (%) 56

6.2.2 Global Cervical Cancer Diagnostics Market Size, By Age Group, 2022 (%) 57

Table of Content

5


6.2.3 Global Cervical Cancer Diagnostics Market, By Age Group (Below 35 years), By Value (2012-2022)

58

6.2.4 Global Cervical Cancer Diagnostics Market, By Age Group (35 years and above), By Value (2012-2022)

59

7. Global Cervical Cancer Diagnostics Market: Regional Analysis 60

7.1 Global Cervical Cancer Diagnostics Market Size, By Region: Breakdown (%) 60

7.1.1 Global Cervical Cancer Diagnostics Market Size, By Region, 2016 (%) 61

7.1.2 Global Cervical Cancer Diagnostics Market Size, By Region, 2022 (%) 62

7.2 North America Cervical Cancer Diagnostics Market: Growth and Forecast 63

7.2.1 By Value (2012-2016) 64

7.2.2 By Value (2017-2022) 65

7.2.3 By Type, By Value (2012-2022) 71

Table of Content

6


7.2.4 By Age Group, By Value (2012-2022) 72

7.3 North America Cervical Cancer Diagnostics Market: Country Analysis (U.S and Canada) 73

7.3.1 U.S Cervical Cancer Diagnostics Market, By Value (2012-2022) 75

7.3.2 U.S Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022) 77

7.3.3 U.S Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022) 78

7.3.4 Canada Cervical Cancer Diagnostics Market, By Value (2012-2022) 80

7.3.5 Canada Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022) 81

7.3.6 Canada Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022) 82

7.4 Europe Cervical Cancer Diagnostics Market: Growth and Forecast 85

7.4.1 By Value (2012-2016) 86

Table of Content

7


7.4.2 By Value (2017-2022) 87

7.4.3 By Type, By Value (2012-2022) 94


7.5 Europe Cervical Cancer Diagnostics Market: Country Analysis (Germany and U.K) 96

7.5.1 Germany Cervical Cancer Diagnostics Market, By Value (2012-2022) 98

7.5.2 Germany Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022) 99

7.5.3 Germany Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022) 100

7.5.4 U.K Cervical Cancer Diagnostics Market, By Value (2012-2022) 102

7.5.5 U.K Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022) 103

7.5.6 U.K Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022) 104

Table of Content

8


7.6 APAC Cervical Cancer Diagnostics Market: Growth and Forecast 106

7.6.1 By Value (2012-2016) 107

7.6.2 By Value (2017-2022) 108

7.6.3 By Type, By Value (2012-2022) 114


7.7 APAC Cervical Cancer Diagnostics Market: Country Analysis (China and India) 116

7.7.1 China Cervical Cancer Diagnostics Market, By Value (2012-2022) 118

7.7.2 China Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022) 119

7.7.3 China Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022) 120

7.7.4 India Cervical Cancer Diagnostics Market, By Value (2012-2022) 122

Table of Content

9


7.7.5 India Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022) 123

7.7.6 India Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022) 124

7.8 ROW Cervical Cancer Diagnostics Market: Growth and Forecast 126

7.8.1 By Value (2012-2016) 127

7.8.2 By Value (2017-2022) 127

7.8.3 By Type, By Value (2012-2022) 129


7.9 ROW Cervical Cancer Diagnostics Market: Country Analysis (Brazil and Mexico) 131

7.9.1 Brazil Cervical Cancer Diagnostics Market, By Value (2012-2022) 133

7.9.2 Brazil Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022) 135

Table of Content


7.9.3 Brazil Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022) 136

7.9.4 Mexico Cervical Cancer Diagnostics Market, By Value (2012-2022) 138

7.9.5 Mexico Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022) 140

7.9.6 Mexico Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022) 141

8. Global Cervical Cancer Diagnostics Market Dynamics 143

8.1 Global Cervical Cancer Diagnostics Market Drivers 144

8.2 Global Cervical Cancer Diagnostics Market Restraints 148

9. Global Cervical Cancer Diagnostics Market Trends 150

10. Porter Five Force Analysis 153

11. SWOT Analysis 155

10

Table of Content


12. Supply Chain Analysis 157

13. Pricing Analysis 159

14. Competitive Landscape: 164

14.1 Company Share Analysis of Key Industry Players 165

14.2 Product Benchmarking of Key Industry Players 167

14.3 Recent Product Approvals of Key Industry Players 169

15. Policy and Regulatory Landscape 170

16. Company Profiling 175

16.1 Hologic 176

16.2 Abott Laboratories 178

11

Table of Content


16.3 Roche 181

16.4 Guided Therapeutics 183

16.5 Becton, Dickinson and Company 185

16.6 Qiagen 187

16.7 Quest Diagnostics 189

16.8 Arbor Vita Corporation 191

17. About Us 192

12

List of Figures

Figure No. Figure Title Page No.

Figure 1: Global Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million) 39

Figure 2: Global Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million) 40

Figure 3: Healthcare Costs Per Capita, By Select Countries, 2015 (USD) 41

Figure 4: World Female Population Estimates, 2017 (In Millions) 43

Figure 5: Age-Standardized Cervical Cancer Incidence Rate (per 100,000 women per year), By Region 43

Figure 6: Top 10 Most Frequent Cancer in Females, World, (Age−standardised incidence rate per 100,000 women) 44

Figure 7: Top 10 Most Frequent Cancer Deaths in Females, World, (Age−standardised incidence rate per 100,000 women)

44

Figure 8: Global Cervical Cancer Diagnostics Market Size, By Type, 2016 (%) 49

Figure 9: Global Cervical Cancer Diagnostics Market Size, By Type, 2022 (%) 50

Figure 10: Global PAP Test Market, By Value, 2012-2016 (USD Million) 51

Figure 11: Global PAP Test Market, By Value, 2012-2016 (USD Million) 51

Figure 12: Global HPV Test Market, By Value, 2012-2016 (USD Million) 52

Figure 13: Global HPV Test Market, By Value, Forecast, 2017-2022 (USD Million) 52

Figure 14: Global Colposcopy Test Market, By Value, 2012-2016 (USD Million) 53

Figure 15: Global Colposcopy Test Market, By Value, Forecast, 2017-2022 (USD Million) 53

Figure 16: Global Cervical Biopsies Market, By Value, 2012-2016 (USD Million) 54

Figure 17: Global Cervical Biopsies Market, By Value, Forecast, 2017-2022, (USD Million) 54

Figure 18: Global Cervical Cancer Diagnostics Market Size, By Age Group, 2016 (%) 56

Figure 19: Global Cervical Cancer Diagnostics Market Size, By Age Group, 2022 (%) 57

13

List of Figures


Figure 20: Global Cervical Cancer Diagnostics Market, By Age Group (Below 35 years), By Value, 2012-2016 (USD Million) 58

Figure 21: Global Cervical Cancer Diagnostics Market, By Age Group (Below 35 years), By Value, Forecast, 2017-2022 (USD Million)

58

Figure 22: Global Cervical Cancer Diagnostics Market, By Age Group (35 years and above), By Value, 2012-2016 (USD Million)

59

Figure 23: Global Cervical Cancer Diagnostics Market, By Age Group (35 years and above), By Value, Forecast, 2017-2022 (USD Million)

59

Figure 24: Global Cervical Cancer Diagnostics Market Size, By Region, 2016 (%) 61

Figure 25: Global Cervical Cancer Diagnostics Market Size, By Region, 2022 (%) 62

Figure 26: North America Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million) 64

Figure 27: North America Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million) 65

Figure 28: North America Healthcare Cost Per Capita, By Select Country, 2016 (USD) 66

Figure 29: North America GDP, 2012-2015 (USD Trillion) 66

Figure 30: North America GDP, By Select Country, 2016 (USD Trillion) 66

Figure 31: United States of America, Per Capita Expenditure on Healthcare, 2012-2016 (USD) 67

Figure 32: Canada, Per Capita Expenditure on Healthcare, 2012-2016 (USD) 67

Figure 33: United States of America, Female Population in the age group 15-64, 2012-2016 68

Figure 34: Canada, Female Population in the age group 15-64, 2012-2016 68

Figure 35: North America Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 71

Figure 36: North America Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 72

Figure 37: U.S. Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million) 75

Figure 38: U.S Health Spending, By Service or Product, 2016 (%) 76

Figure 39: U.S Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 77

14

List of Figures


Figure 40: U.S Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 78

Figure 41: Canada Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million) 80

Figure 42: Canada Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 81

Figure 43: Canada Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 82

Figure 44: North America Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total) 84

Figure 45: North America Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total) 84

Figure 46: North America Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total) 86

Figure 47: Europe Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million) 87

Figure 48: Europe, GDP, By Select Country, 2016, (USD Billion) 89

Figure 49: Europe Health Spending Per Capita, By Select Country, 2016 (USD) 89

Figure 50: United Kingdom, Per Capita Expenditure on Healthcare, 2012-2016 (USD) 90

Figure 51: Germany, Per Capita Expenditure on Healthcare, 2012-2016 (USD) 90

Figure 52: United Kingdom, Female Population in the age group 15-64, 2012-2016 91

Figure 53: Germany, Female Population in the age group 15-64, 2012-2016 91

Figure 54: Europe Medical Technology Market Based on Manufacturer Prices, By Country, 2016 (%) 92

Figure 55: Europe Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 94

Figure 56: Europe Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 95

Figure 57: Germany Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million) 98

Figure 58: Germany Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 99

Figure 59: Germany Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 100

Figure 60: U.K Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million) 102

15

List of Figures


Figure 61: U.K Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 103

Figure 62: U.K Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 104

Figure 63: Europe Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total) 105

Figure 64: Europe Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total) 105

Figure 65: APAC Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million) 107

Figure 66: APAC Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million) 108

Figure 67: APAC, GDP, By Select Country, 2016, (USD Billion) 110

Figure 68: APAC Health Expenditure Per Capita, Public and Private, By Select Country, 2016 (USD) 110

Figure 69: China, Female Population in the age group 15-64, 2012-2016 111

Figure 70: India, Female Population in the age group 15-64, 2012-2016 111

Figure 71: India, Degree of Urbanization, 2012-2016 (in %) 112

Figure 72: China, Degree of Urbanization, 2012-2016, (in %) 112

Figure 73: APAC Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 114

Figure 74: APAC Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 115

Figure 75: China Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million) 118

Figure 76: China Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 119

Figure 77: China Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 120

Figure 78: China Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 122

Figure 79: India Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 123

Figure 80: India Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 124

16

List of Figures


Figure 81: APAC Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total) 125

Figure 82: APAC Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total) 125

Figure 83: ROW Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million) 127

Figure 84: ROW Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million) 129

Figure 85: ROW Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 130

Figure 86: ROW Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 133

Figure 87: Brazil, Female Population in the age group 15-64, 2012-2016 134

Figure 88: Brazil, Degree of Urbanization, 2012-2016 (in %) 134

Figure 89: Brazil Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 135

Figure 90: Brazil Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 136

Figure 91: Mexico Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million) 138

Figure 92: Mexico, Female Population in the age group 15-64, 2012-2016 139

Figure 93: Mexico, Degree of Urbanization, 2012-2016 (in %) 139

Figure 94: Mexico Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 140

Figure 95: Mexico Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 141

Figure 96: ROW Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total) 142

Figure 97: ROW Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total) 142

Figure 98: Global Cervical Cancer Diagnostics Market, By Company Share, 2016 (%) 165

Figure 99: Hologic, Revenue, 2013-2017 (USD Billion) 177

Figure 100: Hologic, Revenue, By Geography, 2017 (%) 177

17

List of Figures


Figure 101: Hologic, Revenue, By Segment, 2017 (%) 177

Figure 102: Abbott Laboratories, Revenue, 2012-2016 (USD Million) 179

Figure 103: Abobott Laboratories, Revenue, By Segment, 2016 (%) 179

Figure 104: Abbott, Revenue, By Geography, 2016 (%) 180

Figure 105: Roche, Revenue, 2012-2016 (USD Million) 182

Figure 106: Roche, Revenue, By Segment, 2016 (%) 182

Figure 107: Roche, Revenue, By Geography, 2016 (%) 182

Figure 108: Guided Therapeutics, Sales, 2012-2016 (USD thousands) 184

Figure 109: BD, Revenue, 2012-2016 (USD Million) 186

Figure 110: BD, Revenue, By Geography, 2017 (%) 186

Figure 111: BD, Revenue, By Segment, 2017 (%) 186

Figure 112: Qiagen, Revenue, 2012-2016 (USD Millions) 188

Figure 113: Qiagen, Revenue, By Geography, 2016 (%) 188

Figure 114: Qiagen, Revenue, By Product Categories, 2016 (%) 188

Figure 115: Quest Diagnostics, Revenue, 2012-2016 (USD Millions) 190

Figure 116: Quest Diagnostics, Revenue, By Business Segments, 2016 (%) 190

18

List of Tables

Table No. Table Title Page No.

Table A: List of Abbreviations 26

Table B: Cervical Cancer Flowchart 34

Table C: Cervical Cancer Screening Recommendations 35

Table D: Cervical Cancer Diagnostics Segmentation Flowchart 37

Table E: Medical Tourism Market Drivers 42

Table F: Medical Tourism Index, By Region and Top Destinations 42

Table G: Recent Company Acquisitions in Cervical Cancer Diagnostics Market 46

Table H: HPV-Associated and HPV-Attributable Cancer Statistics, U.S, 2015 69

Table I: Major Players in cervical cancer diagnostics market in North America 83

Table J: Europe, Female Population aged 15+, By Region, 2017, (In Millions) 88

Table K: Major Players in cervical cancer diagnostics market in Europe 92

Table L: Pricing Analysis of PAP TEST 160

Table M: Pricing Analysis of HPV TEST 161

Table N: Pricing Analysis of Colposcopy Test 162

Table O: Pricing Analysis of Colposcopy Test 163

Table P: Roche, Growth Strategy 166

Table Q: Product Benchmarking of Key Industry Players, By Type 167

Table R: Product Benchmarking of Key Industry Players, By Type 168

Table S: Product Benchmarking of Key Industry Players, By Type 169

19

(c) AZOTH Analytics

For our study on Global Cervical Cancer Diagnostics Market, we have conducted comprehensive

secondary research followed by an extensive primary research. In the process of secondary research,

we have scrutinized industry documents, accessed from open sources, premium paid databases and

our internal knowledge base. In the process of primary research, we have interviewed various industry

experts across the value chain of the medical equipment and service industry.

Market size of the actual period (2012-2016) has been evaluated on the basis of growth trends of

the industry in the last five years, and confirming the findings through primary research. Annual

reports of the companies are scanned to further validate the market size and to estimate the size

of various other applications. Market sizing and growth in the forecast period (2017-2022) is

estimated through revenue mapping, growth of new advance equipment and technology and

historical growth pattern of the industry. All the relevant data points/ statistics in the forecast

period are validated through relevant and reliable primary sources.

Report Focus: Global Cervical Cancer Diagnostics Market.

- By Type (Pap Test, HPV Test, Colposcopy and Cervical Biopsies)

- By Age Group ( Below 35 years and 35 years and above)

- By Region (North America, Europe, Asia Pacific and ROW),

- By Country (U.S., Canada, Brazil, Mexico, Germany, U.K, China and India)

- Company Coverage (Roche, Hologic, Abott Laboratories, Guided Therapeutics, Qiagen, etc.)

Companies Contacted: Qiagen, Recombigen Laboratories

20

Research Methodology

Global Cervical Cancer Diagnostics Market Overview

Source: Azoth Analytics Estimates

xxxx

Xxxx

Xxxx

Xxxx

xxxx

Growing healthcare awareness in addition to increased expenditure in healthcare sector has been

boosting the global cervical cancer diagnostics market.

2012 2013 2014 2015 2016

Figure : Global Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million)

CAGR 2012-2016

xxxx%

21

Global Low Temperature Sterilization Market, By Value

22

Figure : Global Colposcopy Test Market, By Value,

2012-2016 (USD Million)


CAGR 2012-2016

xxxx%

CAGR 2017-2022

xxxx%

Figure : Global Colposcopy Test Market, By Value,

Forecast, 2017-2022 (USD Million)

2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022

Global Colposcopy Test Market

Xxxx

Xxxx

Xxxx

Xxxx

xxxx

xxxxx

Global Cervical Cancer Diagnostics Market- By Age Group

Figure : Global Cervical Cancer Diagnostics Market

Size, By Age Group, 2016 (%)

Female population aged 35 years and above held the major market share of approximately 74.44% in the

year 2016.

Below 35 years

35 years and above


Xxxx

xxxx

Xxxx

xxxx

Xxxx

xxxx

Key Drivers

23


Figure : U.K Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)

CAGR 2012-2016 Pap Test : xx% HPV Test : xx%

Colposcopy : xx% Cervical Biopsies : xx%

U.K Cervical Cancer Diagnostics Market, By Type

Xxxx

xxxx

2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022

Pap Test HPV Test Colposcopy Cervical Biopsies

CAGR 2017-2022 Pap Test : xx% HPV Test : xx%

Colposcopy : xx% Cervical Biopsies : xx%

24

2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022

Pap Test

HPV Test

Colposcopy

Cervical Biopsies


Figure : ROW Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)

CAGR 2012-2016

Below 35 years : xx%

35 years and above : xx%

ROW Cervical Cancer Diagnostics Market, By Age Group

Xxxx

Xxxx

xxxx

2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022

Below 35 years 35 years and above

CAGR 2017-2022

Below 35 years : xx%

35 years and above : xx%

25

2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022

Below 35 years

35 years and above

About Azoth Analytics Pvt Ltd.

Azoth Analytics is a business research and analytics firm that creates in-depth research reports and provides customized research solutions and consultancy services. Verticals in which Azoth Analytics specializes include healthcare and pharmaceutical, oil and gas, retail, chemicals, automotive, FMCG, food & beverages and technology. Azoth creates comprehensive and in-depth research reports by recording, interpreting and analyzing information. Strategic market sizing and data dredging techniques include secondary research, and primary research (interviews with management personnel and industry experts).

Related Reports:

Global Cancer Diagnostics Market: Trends, Opportunities and Forecasts (2016-2021)-(By Type: Imaging Tests, Endoscopy, Biopsy, Tumor

Marker; By Imaging Tests Sub-Type: MRI, Ultrasound, PET-CT Scan, Mammography; By Region: North America, Latin America, APAC,

Europe, MEA)

26

global countertops market size, by value€¦ · guided therapeutics becton, dickinson and company...

Documents